Iowa City, IA17 Active Studies

Ankylosing Spondylitis Clinical Trials in Iowa City, IA

Find 17 actively recruiting ankylosing spondylitis clinical trials in Iowa City, IA. Connect with local research sites and explore new treatment options.

17
Active Trials
17
Sponsors
18,700
Enrolling

Recruiting Ankylosing Spondylitis Studies in Iowa City

About Ankylosing Spondylitis Clinical Trials in Iowa City

Ankylosing spondylitis is a chronic inflammatory disease primarily affecting the spine and sacroiliac joints, causing pain, stiffness, and potentially spinal fusion. It typically begins in early adulthood. Treatment includes NSAIDs, biologics (TNF and IL-17 inhibitors), and physical therapy.

There are currently 17 ankylosing spondylitis clinical trials recruiting participants in Iowa City, IA. These studies are seeking a combined 18,700 participants. Research is being sponsored by National Cancer Institute (NCI), Michael Shy, Johns Hopkins University and 14 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Ankylosing Spondylitis Clinical Trials in Iowa City — FAQ

Are there ankylosing spondylitis clinical trials in Iowa City?

Yes, there are 17 ankylosing spondylitis clinical trials currently recruiting in Iowa City, IA. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Iowa City?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Iowa City research site will contact you about next steps.

Are clinical trials in Iowa City free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Iowa City studies also compensate for your time and travel.

What ankylosing spondylitis treatments are being tested?

The 17 active trials in Iowa City are testing new therapies including novel drugs, biologics, and treatment approaches for ankylosing spondylitis.

Data updated July 19, 2026 from ClinicalTrials.gov